| Market Capitalization (Millions $) |
9 |
| Shares
Outstanding (Millions) |
55 |
| Employees |
16 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-45 |
| Cash Flow (TTM) (Millions $) |
-3 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Medicus Pharma Ltd. is a clinical-stage biotechnology company focused on advancing therapeutic assets through Phase 2 proof-of-concept studies. The company seeks out-licensing or strategic partnerships for late-stage development and commercialization. Medicus Pharma operates through its subsidiaries SkinJect, which develops doxorubicin-containing microneedle arrays for non-melanoma skin diseases such as basal cell carcinoma, and Antev, which develops Teverelix, a gonadotrophin-releasing hormone antagonist for advanced prostate cancer and prevention of acute urinary retention. The company operates in multiple countries and actively acquires and in-licenses assets to expand its portfolio.
Company Address: 300 Conshohocken State Rd W. Conshohocken 19428 PA
Company Phone Number: 636-0184 Stock Exchange / Ticker: NASDAQ MDCX
|
